Bli medlem
Bli medlem

Du är här


AddLife: AddLife acquires Biolin Scientific AB - world leading instruments for material analysis at the nanoscale

AddLife has signed an agreement to acquire all the shares in the
company Biolin Scientific AB, part of the group Biolin Scientific,
owned by Ratos. The Company is a leading Nordic developer and
producer of analytical instruments for material analysis at the
nanoscale. The products are demanded both from universities and
industry all over the world. The business has shown long term
profitability and growth, has an attractive product portfolio and is
world leading within its niche, material science. The ownership will
come effective today and the Company will be part of the business
area Labtech within AddLife. The acquisition is the fourth since the
listing of AddLife in March earlier this year.

The world leading technique, that is the foundation within Biolin
Scientific, is based on innovative academic research at Chalmers, in
measurement technology at the nanoscale. The Company has during
several years had a strong international growth with good
profitability and a turnover of about SEK 100 million. Today the
customers are mainly within research all over the world, both within
the academia and industry. The Company has global sales through their
own subsidiaries in US, UK and China but also through distributors.
The head quarter is in Sweden and research and production are both in
Sweden and Finland. Biolin Scientific AB with its subsidiaries has in
total 61 employees.

- Material analysis at the nanoscale is an expansive and exciting area
where global developments emerge rapidly. As a world leading supplier
of instruments for studies of material characteristics at the
nanoscale Biolin Scientific contribute to creating new innovative
products and solutions in a variety of areas for their customers. We
look forward to the opportunity to further develop the company in a
global market, says Peter Simonsbacka, Business area manager Labtech,
AddLife AB.

The acquisition of BiolinScientific means an expansion of AddLife in
own high-tech products. The acquisition also entails a further
international expansion of AddLife outside the Nordic region.

The acquisition is expected to have a marginally positive effect on
AddLife's earnings per share.

Stockholm December 7, 2016

AddLife AB (publ)

For further information, please contact
Kristina Willgård, CEO, AddLife AB, +46 705 10 12 23
Peter Simonsbacka, Business area manager Labtech, AddLife AB, +46 702
87 00 87

AddLife is an independent player in Life Science that offers
high-quality products, services and advice to both the private and
public sector, mainly in the Nordic region. AddLife has about 460
employees in some 25 subsidiaries that operate under their own
brands. The Group has annual sales of about SEK 1.8 billion. AddLife
shares are listed on NASDAQ Stockholm.

This information is information that AddLife AB is obliged to make
public pursuant to the EU Market Abuse Regulation. The information
was submitted for publication, through the agency of the contact
person set out above, at 08:30 CET on 7 December 2016.


Författare WKR

Tala om vad ni tycker

Tala om vad ni tycker

Ni är just nu inne på en betaversion av nya aktiespararna. Lämna gärna feedback på vad ni tycker i formuläret nedan.